1.Ileal Malignant Melanoma Presenting as a Mass with Aneurysmal Dilatation: A Case Report.
Wook KIM ; Jong Min BAEK ; Young Jin SUH ; Hae Myung JEON ; Jean A KIM
Journal of Korean Medical Science 2004;19(2):297-301
Malignant melanoma is the most common metastatic tumor of the gastrointestinal tract and can present with fairly common constitutional symptoms. A 36-yr-old woman was found to have a secondary malignant melanoma in the terminal ileum with profuse aneurysmal dilatation, which is not the typical presentation of the malignant melanoma in the small intestine. Radiologic studies revealed a large tumor involving the distal ileum with aneurysmal dilatations having afferent and efferent loops, which needed to be differentiated from malignant lymphoma and other gastrointestinal tumors. Exploratory laparotomy was done, and we found a huge mass with plentiful aneurysmal dilatations; much the same of the findings from the previous studies. Segmental resection with the surrounding omentum was done followed by end-to-end anastomosis between both ends of the remaining ileum. She had been free from any evidence of the local or systemic recurrence for one year after the completion of eighteen months of the subcutaneous interferon treatment; postoperatively however, the occurrence of metastatic mass at the right axilla rendered us from complete resection due to severe penetration into the vital nerves and vessels in the axilla.
Adult
;
Dilatation, Pathologic
;
Female
;
Human
;
Ileal Neoplasms/*secondary
;
Ileum/*pathology
;
Melanoma/*secondary
;
Neoplasm Recurrence, Local/pathology
;
Neoplasms, Unknown Primary/*pathology
2.Diagnostic value of dual-head 18F-FDG imaging in metastatic lesion with unknown primary tumour.
Yan-ji PAN ; Guang-yu WEI ; Yan-lin FENG ; Feng-wen YU ; De-jun LIU ; Ning ZHANG
Chinese Journal of Oncology 2005;27(9):565-566
OBJECTIVETo investigate the diagnostic value of dual-head (18)F-fluorodeoxyglucose ((18)F-FDG) imaging in metastatic lesion with unknown primary tumour (UPT).
METHODSSeventy patients with UPT underwent dual-head (18)F-FDG imaging after iv (18)F-FDG 1.85 MBq/kg. The primary tumour was diagnosed according to the FDG uptake and T/N value.
RESULTSOf the 70 patients, the primary tumour was identified by positive FDG imaging and finally confirmed pathologically in 58 patients (82.9%), and 12 patients had a negative FDG imaging (17.1%). Forty-two of the 58 positive patients were found to have lung cancer (72.4%). Among the 12 negative patients, their primary tumour was then identified by other diagnostic procedures in 5 patients (41.7%), in 1 patient, the primary site was detected during follow-up, however, the primary tumour was never detected in the rest 6 patients.
CONCLUSIONDual-probe (18)F-FDG imaging is a simple, quick, non-invasive and sensitive technique with an accuracy over 80% in the diagnosis of unknown primary tumour. The lung is found to be the most frequent primary site. Dual-probe (18)F-FDG imaging can be recommended as the first diagnostic choice for UPT.
Female ; Fluorodeoxyglucose F18 ; Humans ; Lung Neoplasms ; diagnostic imaging ; pathology ; Lymph Nodes ; diagnostic imaging ; pathology ; Lymphatic Metastasis ; Male ; Neoplasms, Unknown Primary ; diagnostic imaging ; pathology ; Positron-Emission Tomography
3.Investigation of the characters of cervical lymph node metastases of primary malignant tumor beyond head and neck.
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2007;42(6):413-416
OBJECTIVETo investigate the characters of cervical lymph node metastases of primary tumors beyond head and neck.
METHODSAmong 466 cases of malignant tumor with cervical lymph node metastases treated in Peking Union Medical College Hospital from January 1989 to June 2004, 77 cases of tumor which sites primarily beyond head and neck were studied. Retrospective analysis of their clinical characters was done by LEVEL system.
RESULTSThe primary sites of these 77 cases of malignant tumor consisted of lung, stomach, esophagus, galactophore, colon, mediastinum, ovary, uterus, pancreas, liver, mesentery, adrenal gland and rectum. The frequency of cervical lymph node metastases was 81.8% (63/77) in LEVEL V (50 in the left), 11.7% (9/77) in LEVEL IV, 5.2% (4/77) in LEVEL III, 1.3% (1/77) in LEVEL I separately. The proportion of the metastases of malignant tumor from primary site beyond head and neck in each region was 2.1% in LEVEL I, 3.7% in LEVEL III, 14.3% in LEVEL IV, 70.8% in LEVEL V. Among the cervical lymph node metastases of primary tumor beyond head and neck, 51.9% were low-grade adenocarcinoma, 15.6% were medial-grade adenocarcinoma, 11.7% were low-grade squamous cell carcinoma, 10.4% were medial-grade squamous carcinoma.
CONCLUSIONSThe cervical lymph node metastases of malignant tumor might be seen from many organs beyond head and neck. The metastases from primary sites beyond head and neck usually focus on LEVEL V (81.8%), especially in the left. And the primary tumors beyond head and neck metastasis in this region were more than the tumors from head and neck locally. The histological type of the primary tumors were frequently low-medial grade carcinomas.
Adult ; Aged ; Female ; Humans ; Lymph Nodes ; pathology ; Lymphatic Metastasis ; pathology ; Male ; Middle Aged ; Neck ; Neoplasms, Unknown Primary ; pathology ; Retrospective Studies ; Young Adult
4.Dermatomyositis Associated with Cancer of Unknown Primary Site.
Hyung Il KIM ; Sung Hoon CHUNG ; Jun Eul HWANG ; Sang Ho KIM ; Jae Sook AHN ; Duk Hwan YANG ; Yoe Kyeoung KIM ; Sook Jung YUN ; Sang Hee CHO ; Je Jung LEE ; Ik Joo CHUNG ; Hyeoung Joon KIM
Journal of Korean Medical Science 2007;22(Suppl):S174-S177
Dermatomyositis (DM) is an uncommon inflammatory myopathy with characteristic rash accompanying, or more often preceding, muscle weakness. There is a well-recognized association between DM and several cancers, such as ovarian cancer, breast cancer, melanoma, colon cancer, and non-Hodgkin lymphoma. We report the first case of cancer of unknown primary site associated with DM. A 62-yr-old woman presented to us with both shoulder painful swelling and facial edema. She was diagnosed previously as cancer of unknown primary site, histologically confirmed with squamous cell carcinoma in a pelvic mass. For the following days, she complained of erythematous face followed by progressive weakness of the proximal muscles of upper and lower limbs. The laboratory tests showed an increased muscle enzyme and acute phase reactants. The electromyogram showed the typical findings of DM. After the treatment with high dose steroid and methotrexate, the proximal motor weakness improved, and she received palliative radiation therapy.
Carcinoma, Squamous Cell/complications/diagnosis/pathology
;
Dermatomyositis/*complications/diagnosis/pathology/therapy
;
Female
;
Humans
;
Middle Aged
;
Neoplasms, Unknown Primary/*complications/diagnosis/pathology
5.Diagnosis and treatment of the pituitary metastases.
Wei LIAN ; Zuyuan REN ; Changbao WU
Chinese Medical Sciences Journal 2004;19(1):68-71
Three cases of pituitary metastases were reported. They all had operations and the pathological examination confirming the diagnosis. The clinical features of diabetes insipidus and extraocular nerve palsy were presented. In two cases, the original tumors were bronchioloalveolar carcinoma; in the other one, the original tumor was unknown. All three cases had poor outcome. These cases illustrate the fact that a pituitary metastasis can closely mimic a pituitary benign tumor, such as pituitary adenoma. Especially in the presence of suggestive symptoms such as diabetes insipidus and/or cranical nerve paralysis, the possibility of metastatic disease in the differential diagnosis of a pituitary mass should always be considered.
Adenocarcinoma
;
secretion
;
surgery
;
Adenocarcinoma, Bronchiolo-Alveolar
;
secondary
;
surgery
;
Adult
;
Aged
;
Female
;
Humans
;
Lung Neoplasms
;
pathology
;
Male
;
Middle Aged
;
Neoplasms, Unknown Primary
;
Pituitary Neoplasms
;
secondary
;
surgery
6.A clinical study of 27 cases of cervical metastatic carcinoma of unknown primary site.
Wenjing LI ; Ding XIN ; Qingfeng ZHANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2015;29(13):1187-1190
OBJECTIVE:
To analyze the clinical feature of cervical metastatic carcinoma of unknown primary site (CCUP) for guiding clinical diagnosis and treatment.
METHOD:
Twenty-seven cases of CCUP during May 2007 to September 2013 in department were analyzed retrospectively. Kaplan-Meier method and Log-rank test were used for survival analysis, multivariate analysis using the Cox regression model.
RESULT:
There is no significant influence among gender, age and the mass position on the median survival time. Median survival time of patients with different pathological types was statistically significant (P < 0.05). Treatment affected the median surial significantly (P < 0.05) and also was the independent prognostic factors (P < 0.05).
CONCLUSION
The early establishment of pathological type and primary focal position can improve the prognosis. Taking treatment according to pathological types can increase the patient's survival rate. Combined treatment can prolong the patient's survival time.
Carcinoma
;
diagnosis
;
secondary
;
Combined Modality Therapy
;
Head and Neck Neoplasms
;
diagnosis
;
secondary
;
Humans
;
Multivariate Analysis
;
Neoplasms, Unknown Primary
;
pathology
;
Prognosis
;
Retrospective Studies
;
Survival Analysis
;
Survival Rate
7.Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute.
Yooju SHIN ; Sang Yun HA ; Jiyeon HYEON ; Boram LEE ; Jeeyun LEE ; Kee Taek JANG ; Kyoung Mee KIM ; Young Suk PARK ; Cheol Keun PARK
Cancer Research and Treatment 2015;47(4):738-746
PURPOSE: Management of gastroenteropancreatic (GEP) neuroendocrine tumors with liver metastases (NETLM) presents many clinical challenges. Assessment of the extent of disease and primary tumor site is crucial for management. In this study, we investigated the primary tumor sites and prognostic factors in GEP NETLM among Korean patients. MATERIALS AND METHODS: We reviewed the medical records of 72 Korean patients diagnosed with GEP NETLM between January 1999 and May 2013, focusing on their clinical and pathologic characteristics. RESULTS: The most frequently encountered primary tumor sites were the pancreas (n=25, 35%), stomach (n=8, 11%), gall bladder (n=4, 6%) and rectum (n=3, 4%). Twenty-five patients (35%) had occult primary tumor. Twelve patients (17%) had histological grade G1 tumors, 30 patients (42%) had G2 tumors, and 30 patients (42%) had G3 tumors. The mean follow-up period after histological confirmation of hepatic metastases was 11.30+/-2.44 months for G3 tumors, 19.67+/-4.09 months for G2 tumors, and 30.67+/-6.51 months for G1 tumors. Multivariate analyses revealed that an unknown primary tumor site (p=0.001) and higher histological grade (p < 0.001) were independent prognostic indicators for shorter overall survival (OS). Most long-term survivors (OS > 24 months) had received antitumor treatment. CONCLUSION: The primary tumor site most frequently associated with GEP NETLM was the pancreas. Unknown primary tumor and higher histological grade were independent prognostic indicators for shorter OS. Patients identified as being at a risk of shorter OS should be followed up closely.
Follow-Up Studies
;
Humans
;
Korea*
;
Liver*
;
Medical Records
;
Multivariate Analysis
;
Neoplasm Metastasis*
;
Neoplasms, Unknown Primary
;
Neuroendocrine Tumors*
;
Pancreas
;
Pathology
;
Prognosis
;
Rectum
;
Stomach
;
Survivors
;
Urinary Bladder
8.Diagnostic value of bone marrow biopsy for bone marrow metastatic tumor with unknown primary tumor site.
Ying WU ; Li-qing YAO ; Jie CHENG ; Hong TIAN
Journal of Southern Medical University 2010;30(5):1069-1071
OBJECTIVETo explore the diagnostic value of bone marrow biopsy for bone marrow metastatic tumor with unknown primary tumor site.
METHODSThirty-eight cases of metastatic bone marrow tumors were diagnosed by light microscopy, and the bone marrow samples from these cases with unknown primary tumor sites were examined by immunohistochemistry.
RESULTSIn all the cases, the bone marrow was infiltrated by tumor cells between the bone trabecula. Twenty patients were identified to have poorly differentiated adenocarcinomas, 6 had mucinous adenocarcinomas, 6 had mucinous carcinomas, 4 had poorly differentiated squamous cell carcinomas, and 2 had melanoma. Immunohistochemistry identified the primary tumor sites in these cases, including 12 stomach cancers, 10 breast cancers, 8 prostate cancers, 4 lung cancers, 1 dorsal melanoma, 1 left foot melanoma, and 2 nasopharyngeal cancers.
CONCLUSIONProper immunohistochemistry can help determine the primary tumor sites in patients with metastatic bone marrow tumor with unknown primary tumor sites.
Adenocarcinoma ; diagnosis ; pathology ; secondary ; Adult ; Aged ; Biopsy, Needle ; Bone Marrow Examination ; methods ; Bone Marrow Neoplasms ; diagnosis ; pathology ; secondary ; Female ; Humans ; Lung Neoplasms ; diagnosis ; pathology ; Male ; Middle Aged ; Neoplasms, Unknown Primary ; diagnosis ; Stomach Neoplasms ; diagnosis ; pathology
9.What is the Clinical Significance of Transudative Malignant Pleural Effusion?.
Jeong Seon RYU ; Seong Tae RYU ; Young Shin KIM ; Jae Hwa CHO ; Hong Lyeol LEE
The Korean Journal of Internal Medicine 2003;18(4):230-233
BACKGROUND: A few reports of transudative malignant effusion on a small number of patients have suggested the need to perform routine cytologic examination in all cases of transudative pleural effusion, whether encountered for malignancy or not. The purpose of this study was to investigate whether cytologic examination should be performed in all cases of transudative pleural effusion for the diagnosis of malignancy. METHODS: We performed a retrospective study of 229 consecutive patients with malignant pleural effusion, proven either cytologically or with biopsy. In patients with transudative pleural effusion, we reviewed medical records, results of transthoracic echocardiography, fiberoptic bronchoscopy, chest X-ray, chest CT scan, and ultrasonogram of the abdomen. These data were examined with particular attention to identifying whether or not the malignancy was suggested on chest X-ray, examining the involvement of the superior vena cava, great vessels, and lymph nodes, determining the presence of pericardial effusion, and observing the endobronchial obstruction. RESULTS: Transudative malignant pleural effusion was observed in seven (3.1%) of the 229 patients, and was caused either by the malignancy itself (6 patients) or by coexisting cardiac diseases (1 patient). All the patients showed evidence suggesting the presence of malignancy at the time of initial thoracentesis, which facilitated the decision of most clinicians on whether to perform cytologic examination for the diagnosis of malignancy. CONCLUSION: Therefore, in all cases of transudative pleaural effusion, no clinical implications indicating malignancy were found on cytologic examination.
Biopsy
;
Carcinoma/classification/*pathology/*secondary
;
Exudates and Transudates
;
Human
;
Lung Neoplasms/*pathology
;
Lymphatic Metastasis
;
Neoplasm Staging
;
Neoplasms, Unknown Primary/*pathology
;
Pleural Effusion, Malignant/metabolism/*pathology
;
Retrospective Studies
;
Support, Non-U.S. Gov't
10.Classification and regression tree analysis of 154 patients with cancer of unknown primary.
Zi-ping WANG ; Yu-tao LIU ; Juan YANG
Chinese Journal of Oncology 2010;32(9):690-693
OBJECTIVETo explore the prognostic factors and their impact on survival of patients with cancer of unknown primary (CUP).
METHODSThe clinical and follow up data of 154 CUP patients referred to the Cancer Hospital & Institute, Chinese Academy of Medical Sciences from January 1, 2003 to December 31, 2007 were analyzed. Multivariate analysis of survival was performed using recursive partitioning referred to as classification and regression tree (CART) analysis.
RESULTSThe median survival for 154 eligible consecutive CUP patients was 18.2 months, and the 5-year survival rate was 1.3%. CART was performed with an initial split on age of 34, and 5 terminal subgroups were formed. The median survival of the 5 subsets ranged from 5.5 months (younger than 34 years old subgroup) to 61.8 months for patients at age of 34 to 60, with one or two organ sites involved, and non-adenocarcinoma histology subsets.
CONCLUSIONSCART can be used to identify previously unappreciated patient subsets and is a useful method for dissecting complex clinical situations and identifying homogeneous patient populations in clinical practice and future clinical trials.
Adenocarcinoma ; pathology ; secondary ; Adult ; Aged ; Bone Neoplasms ; secondary ; Carcinoma, Squamous Cell ; pathology ; secondary ; Female ; Follow-Up Studies ; Humans ; Liver Neoplasms ; secondary ; Lymphatic Metastasis ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasms, Unknown Primary ; classification ; pathology ; Regression Analysis ; Survival Rate